Lexicon: Q3 Earnings Snapshot
By AP News
Published - Nov 12, 2024, 04:26 PM ET
Last Updated - Nov 12, 2024, 04:26 PM EST
THE WOODLANDS, Texas (AP) — THE WOODLANDS, Texas (AP) — Lexicon Pharmaceuticals Inc. (LXRX) on Tuesday reported a loss of $64.8 million in its third quarter.
On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 18 cents.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The drugmaker posted revenue of $1.8 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected $3.1 million.
